OVAGEN
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.
OVAGEN
Industry:
Biotechnology
Founded:
2000-01-01
Address:
Mayo, Mayo, Ireland
Country:
Ireland
Website Url:
http://www.ovagen.ie
Total Employee:
1+
Status:
Active
Contact:
+353 (0)96 75579
Total Funding:
3.37 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Ovagen
Official Site Inspections
http://www.ovagen.ie
- Host name: 73.0.153.160.host.secureserver.net
- IP address: 160.153.0.73
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Ovagen"
Ovagen – Production of germ free eggs and antibodies by Ovagen
Ovagen Group Limited recently attended the 11th Annual Avian Model Systems Conference at the University of Plymouth, UK (11-14SEP2023). It was a wonderful four days of fantastic avian …See details»
Ovagen - Crunchbase Company Profile & Funding
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical …See details»
Irish biotech Ovagen believes study can 'transform' global vaccine ...
Jul 23, 2025 Project director Dr Martin Murphy, Ovagen co-founder and CEO Dr Catherine Caulfield; Dr Leonard Moran, Ovagen co-founder and chair. Wed, 23 Jul, 2025 - 09:00 Martin …See details»
Mayo biotech firm Ovagen raises €2m | ThinkBusiness
Oct 29, 2024 €2m investment in Ovagen to power innovation in vaccine manufacturing. Ballina-based biotech business Ovagen has raised €2m in a Series A equity investment round led by …See details»
WDC supports €1.1M investment in Mayo biotech …
Feb 3, 2023 Their support, along with the tireless dedication of the Ovagen team, puts us in a very strong position as we prepare to go to market with the world’s first germ-free egg.” Declan MacFadden, spokesperson for HBAN’s …See details»
EU funding enables Ovagen to tackle global vaccine market
Dec 6, 2022 Ovagen has recently been awarded European Innovation Council (EIC) Accelerator funding of €10 million between Grant and Equity, placing the company in the top 7% of …See details»
About Us - Ovagen
The Ovagen team has a wealth of technical, operational, financial and management experience. Our Research and Development team has 100 years of combined life-sciences related R&D experience. Ovagen is a biotechnology …See details»
Irish Biotech Ovagen delivers breakthrough in vaccine …
Jul 23, 2025 Study demonstrates 7,000+ doses of yellow fever virus 17D per egg in industry breakthrough. Ovagen Group Limited, an innovation-led Irish biotech, has today announced …See details»
Mayo biotech Ovagen raises €2m and plans to hire 60
Oct 29, 2024 Ovagen, the Mayo-based biotech behind the world’s first germ-free eggs for vaccine development has raised €2m in a Series A equity investment round led by the Western Development Commission (WDC).See details»
HBAN leads €1.1m. investment in Mayo biotech …
Feb 3, 2023 HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTradeIreland, has announced that its …See details»
Cracking success: Mayo firm that developed world’s …
Feb 3, 2023 The world’s first producer of germ-free eggs Ovagen has raised €1.1m in an oversubscribed funding round led by HBAN (Halo Business Angel Network) syndicates Irrus Investments and WxNW. Ovagen’s ground-breaking …See details»
Irish biotech Ovagen's germ-free egg tech produces breakthrough …
3 days ago Ovagen Group Limited, the Irish biotech, has announced groundbreaking results from a Yellow Fever virus yield study that could transform the economics of global vaccine …See details»
Ovagen
Study demonstrates 7,000+ doses of yellow fever virus 17D per egg in industry breakthrough. 23 rd July 2025 Mayo, Ireland: Ovagen Group Limited,an innovation-led Irish biotech, has today …See details»
Irish Biotech Ovagen Delivers Breakthrough in Vaccine …
Jul 23, 2025 Study demonstrates 7,000+ doses of yellow fever virus 17D per egg in industry breakthrough . WDC-backed, Ovagen Group Limited, an innovation-led Irish biotech, has …See details»
WDC leads €2m investment in biotechnology company Ovagen
Oct 29, 2024 The Western Development Commission (WDC) has led a €2 million Series A equity investment round in Ovagen, a biotechnology company based in Ballina, Co Mayo. The …See details»
HBAN leads €1.1M investment in Mayo biotech company, Ovagen …
Feb 9, 2023 Email: [email protected]; Web: www.ovagen.ie; About HBAN. HBAN is a joint initiative of Enterprise Ireland and InterTradeIreland, dedicated to the all-island promotion of …See details»
Biotech company secures €2m - madein.ie
Nov 1, 2024 Ovagen’s germ-free eggs eliminate the issue of vaccine batches failing due to bacterial contamination, which is costing the pharmaceutical industry hundreds of millions of …See details»
Irish Biotech Ovagen Delivers Breakthrough in Yellow Fever …
Jul 24, 2025 The results of the Pirbright Institute study using Ovagen’s technology demonstrated that: Ovagen Germ Free eggs resulted in 7,606 doses of Yellow Fever vaccine per egg …See details»
WDC Leads €2m Investment in Ovagen, Pioneering Innovation in …
Oct 30, 2024 Ovagen is a prime example of how WIF investments can catalyse significant advances in technology, attract further private and public investment, and create long-term …See details»
Press Release: Irish Biotech Ovagen Delivers Breakthrough in …
Jul 23, 2025 Study demonstrates 7,000+ doses of yellow fever virus 17D per egg in industry breakthrough. 23 rd July 2025 Mayo, Ireland: Ovagen Group Limited,an innovation-led Irish …See details»